补充维生素D3与欧米伽-3脂肪酸对VITAL试验中体能指标的影响
VITAL试验的辅助研究纳入1054名基线及2年随访时进行现场评估的成年人,采用2×2析因设计随机接受维生素D3 2000 IU/天和/或海洋欧米伽-3脂肪酸1 g/天或安慰剂。2年后,各随机组的步行速度和计时起立-行走测试均恶化;维生素D3组与安慰剂组、欧米伽-3组与安慰剂组在握力、步行速度、简易体能状况量表及计时起立-行走测试的变化上均无差异。
要点
- 补充维生素D3或海洋欧米伽-3脂肪酸2年未改善一般健康成人的体能指标。
- 2年后所有随机组的步行速度和计时起立-行走测试均出现恶化。
- 基线总25-羟基维生素D高于中位数者,补充维生素D3后计时起立-行走测试较安慰剂组轻度恶化(P=0.01,交互作用P=0.04)。
核心结论
- 在该一般健康成人人群中,补充维生素D3或海洋欧米伽-3脂肪酸2年均未改善体能表现。
研究设计与样本
- VITAL是一项双盲、安慰剂对照随机试验,在25871名美国成年人中评估补充维生素D3和/或欧米伽-3脂肪酸对癌症和心血管疾病的预防作用。
- 本辅助研究在新英格兰亚队列中完成,该亚队列在基线及2年随访时接受现场评估,共纳入1054名参与者(男性≥50岁,女性≥55岁),在波士顿临床研究中心进行。
- 干预采用2×2析因设计:补充维生素D3(胆钙化醇,2000 IU/天)和/或海洋欧米伽-3脂肪酸(1 g/天)。
主要发现
- 2年时,所有随机组的步行速度和计时起立-行走测试均恶化。
- 维生素D3治疗组与安慰剂组之间、欧米伽-3治疗组与安慰剂组之间,握力、步行速度、简易体能状况量表(步行速度、平衡和椅子站立试验的复合指标)及计时起立-行走测试的变化均无差异。
- 总体效应未因性别、年龄、体质指数或基线总/游离25-羟基维生素D或血浆欧米伽-3指数而改变;在基线总25-羟基维生素D水平高于中位数的参与者中,与安慰剂相比,补充维生素D3后计时起立-行走测试轻度恶化(P=0.01;交互作用P=0.04)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Declining muscle strength and performance in older adults are associated with falls, fractures, and premature death. OBJECTIVE: This work aimed to determine whether supplementation with vitamin D3 or omega-3 fatty acids vs placebo for 2 years improves physical performance measures. METHODS: VITamin D and OmegA-3 TriaL (VITAL) was a double-blinded, placebo-controlled randomized trial of supplemental vitamin D3 and/or omega-3 fatty acids vs placebo in the prevention of cancer and cardiovascular disease in 25 871 US adults. This ancillary study was completed in a New England subcohort that had in-person evaluations at baseline and 2-year follow-up. This study was conducted with 1054 participants (age: men ≥50 and women ≥55 years) at the Center for Clinical Investigations in Boston. Interventions included a 2 × 2 factorial design of supplemental vitamin D3 (cholecalciferol, 2000 IU/day) and/or marine omega-3 fatty acids (1 g/day). Main outcome measures included 2-year changes in physical performance measures of grip strength, walking speed, standing balance, repeated chair stands, and Timed-up and Go (TUG). RESULTS: At 2 years, all randomized groups showed worsening walking speeds and TUG. There were no differences in changes in grip strength, walking speeds, Short Physical Performance Battery (composite of walking speed, balance, and chair stands), and TUG between the vitamin D3-treated and the placebo-treated groups and between the omega-3-treated and the placebo-treated groups. Effects overall did not vary by sex, age, body mass index, or baseline measures of total or free 25-hydroxyvitamin D (25[OH]D) or plasma omega-3 index; TUG slightly worsened with vitamin D supplementation, compared to placebo, in participants with baseline total 25(OH)D levels above the median (P = .01; P for interaction = .04). CONCLUSION: Neither supplemental vitamin D3 nor marine omega-3 fatty acids for 2 years improved physical performance in this generally healthy adult population.
引用
- Chou SH, Cook NR, Kotler G, et al. Effects of Supplemental Vitamin D3, Omega-3 Fatty Acids on Physical Performance Measures in the VITamin D and OmegA-3 TriaL. J Clin Endocrinol Metab. 2024. PMID: 38488491. doi:10.1210/clinem/dgae150
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。